期刊文献+

HIV-1基因型、假病毒表型与活病毒表型耐药检测结果的比较 被引量:5

Comparison of genotype,pseusovirus phenotype and native virus phenotype of HIV-1 resistance
原文传递
导出
摘要 目的本研究旨在探讨HIV-1基因型、假病毒表型与活病毒表型耐药检测结果间的差异。方法采用逆转录和套式PCR方法检测4例HIV-1阳性患者逆转录酶与蛋白酶的编码区基因变异,并与假病毒表型及活病毒表型耐药检测结果相比较,分析三者间的差异。结果基因型耐药结果和活病毒表型耐药相比较存在不一致的情况,其中去羟肌苷:100%不一致,司他夫定:50%不一致,齐多夫定:25%不一致,依非韦伦和拉米夫定的结果 100%一致。假病毒与活病毒表型方法分别检测两株病毒对五种药物的表型耐药,共得到10个结果,其中9个结果在耐药解释及耐药程度上均高度一致,仅一株病毒对于齐多夫定的耐药结果存在程度上的差异(假病毒方法为中度耐药,而活病毒方法为高度耐药)。结论 HIV-1基因型与表型耐药检测结果存在差异,假病毒表型与活病毒表型耐药检测方法结果高度一致,存在替代活病毒方法的可能。 Objective To investigate the difference among HIV-1 genotype, pseudovirus phenotype and native virus phenotype resistance results. Methods The gene mutation in reverse transcriptase and protease coding region of HIV-1 positive patients was detected by reverse transcription and nested PCR. The difference among genotype resistance, pseudovirus phenotype and native virus phenotype results was compared and analyzed. Results There was discordance between genotype and native virus phenotype resistance: didanosine: 100%, 2'-3'-didehydro-2'-3'-dideoxythymidine: 50%, azidothymidine: 25%. It was 100% consistent for efavirenz and lamivudine. Pseudovirus and native virus phenotype resistance were detected in two strains for five kinds of drugs and the results were highly consistent. Conclusions There was difference between HIV-1 genotype and phenotype resistance results and high consistency between pseudovirus phenotype and native virus phenotype resistance results. The pseudovirus phenotype could be an alternative method for native virus phenotype.
出处 《中华实验和临床感染病杂志(电子版)》 CAS 2014年第3期5-9,共5页 Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition)
基金 国家十二五重大专项基金项目(No.2012ZX10001-006)
关键词 人类免疫缺陷病毒1型 耐药 基因型 假病毒表型 活病毒表型 Human immunodeficiency virus-1 (HIV-1) Resistance Genotype Pseudovirus genotype Native virus phenotype
  • 相关文献

参考文献14

  • 1Sabin CA, Hill T, Lampe F, et al. Treatment exhaustion of highly active antiretroviral therapy (HAART) among individuals infected with HIV in the United Kingdom: multicentre cohort study[J]. BMJ,2005,330(7493):695-699.
  • 2Hanna GJ. HIV-I genotypic and phenotypic resistance[J]. Clin Lab Med,2002,22(3):637-649.
  • 3Japour AJ, Mayers DL, Johnson VA, et al. Standardized peripheral blood mononuclear eell culture assay for determination of drug susceptibilities of clinical human immunodeficiency virus type I isolates[J]. Antimicrob Agents Chemother,1993,37(5): 1095-1101.
  • 4Platt EJ, Wehrly K, Kuhmann SE, et al. Effects ofCCR5 and CD4 cell surface concentrations on .infections by macrophagetropic isolates of human immunodeficiency virus type I [J]. J Virol, 1998, 72( 4 ):2855-2864.
  • 5Han X, Ouyang W, Liu B, et al. Enantioselective inhibition of reverse transcriptase (RT) of HIV-I by non-racemic indole-based trifluoropropanoates developed by asymmetric catalysis using recyclable organocatalysts[J]. Org Biomol Chem,2013, 11(48):8463-8475.
  • 6Ma L, Sun J, Xing H, et al. Genotype and phenotype patterns of drug-resistant HIV-I subtype B'(Thai B) isolated from patients failing antiretroviral therapy in China[J]. J Acquir Immune Defic Syndr,2007,44(l): 14-19.
  • 7孙坚萍,马丽英,黄江虹,余小玲,徐维泗,纪燕,黄洋,邵一鸣.TZM-b1细胞系检测我国HIV-1病毒表型耐药性[J].中国艾滋病性病,2008,14(5):439-441. 被引量:9
  • 8李亮助,李琳.一种新的HIV-1潜伏感染模型的建立方法[J].医药前沿,2012,2(3):41-42.
  • 9Sarmati L, Nicastri E, Parisi SG, et al. Discordance between genotypic and phenotypic drug resistance profiles in human immunodeficiency virus type 1 strains isolated from peripheral blood mononuclear cells[J]. J Clin Microbiol,2002,40(2):335-340.
  • 10Hanna GJ, D' Aquila RT. Clinical use of genotypic and phenotypic drug resistance testing to monitor antiretroviral chemotherapy[J]. Clin Infect Dis,2001,32(5):774-782.

二级参考文献17

  • 1Xin-ping LIP ,Hui XING ,Zhe WANG ,Xue-feng SI,Lian-en WANG ,Hua CHENG ,Wei-guo CUI ,Shu-lin JIANG ,Ling-jie LIAO ,Hai-wei ZHOU ,Jiang-hong HUANG ,Hong PENG ,Peng-fei MA ,Yi-ming SHAO.Study of HIV-1 Drug Resistance in Patients Receiving Free Antiretroviral Therapy in China[J].中国病毒学,2007,22(3):233-240. 被引量:9
  • 2Larder BA, Darby G, Riehman DD. HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy[ J ]. Science, 1989, 243(4899) :1731 1734.
  • 3Larder BA, Chesebro B, Richman DD. Susceptibilities of zidovudine- susceptible and-resistant human immunodeficiency virus isolates to an- tiviral agents determined by using a quantitative plaque reduction assay [ J ]. Antimicrob Agents Chemother, 1990,34 : 436 - 441.
  • 4Japour AJ, Mayers DL, Johnson VA, et al.Standardized peripheral blood mononuelear eeU culture assay for determination of drug susceptibilities of clinical human immunodeficieney virus type 1 isolates. The RV - 43 Study Group,the AIDS Clinical Trials Group Virology Committee Resistance Working Group[J ]. Antimierob. Agents Chemother, 1993,37:1095 - 1101.
  • 5Yamada O., Matsumoto T., Sasoaka R., et al. Variations in growth eapaeity of HIV in peripheral blood mononuelear cells preparations from different individuals[ J ]. AIDS, 1990,4 : 35 - 40.
  • 6Platt EJ,Wehrly K,Kuhrnann S.E,et al.Effeets of CCR5 and CD4 cell surface concentrations on infection by macrophage tropic isolates of human immunodeficiency virus typel [J]. J Virot, 1998,72:2855 - 2864.
  • 7Wei X,Decker JM, Liu H, et al. Emergence of Resistant Human Immunodeficiency Virus Type 1 in Patients Receiving Fusion Inhibitor ( T - 20) Monotherapy [ J ] . Antimicrob Agents Chemother, 2002,46 : 1896 1905.
  • 8Montefiori DC. Evaluating neutralizing antibodies against HIV, SIV and SHIV in luciferase reporter gene assays [ M ] . Curr Protoc Immunol,2005 ,Chapter 12 : Unit 12.11.
  • 9Hollinger FB, Bremer JW, Myers LE, et al. Standardization of sensitive human immunodeficiency virus coculture procedures and establishment of a multicenter quality assurance program for the AIDS Clinical Trials Group. The NIH/NIAID/DAIDS/ACTG Virology Laboratories[J]. J Clin Microbiol, 1992,30 ; 1787 - 1794.
  • 10Sarmati L, Nicastri E, Parisi SG, et al. Discordance between genotypie and phenotypie drug resistance profiles in human immunodefieieney virus type 1 strains isolated from peripheral blood mononuclear cells [J]. J Clin Mierobiol,2002,40:335 - 340.

共引文献8

同被引文献47

  • 1张驰宇,徐顺高,黄新祥.一种新颖简便的荧光实时RT-PCR相对定量方法的建立[J].生物化学与生物物理进展,2005,32(9):883-888. 被引量:129
  • 2仇超,彭虹,黄相刚,任莉,潘翔,邵一鸣,徐建青.携带绿色荧光蛋白基因的单轮感染活性HIV假病毒的建立及其活性检测[J].中华微生物学和免疫学杂志,2006,26(5):394-398. 被引量:14
  • 3Han X, Zhang M, Dai D, et al. Genotypic resistance mutations to antiretroviral drugs in treatment- naive HIV/AIDS patients liv- ing in Liaoning province, China: baseline prevalence and sub- type- specific difference[ J]. AIDS Res Hum Retroviruses, 2007, 23 (3) :357-364.
  • 4Swafford KL. PAUP 4,0: Phylogenetic analysis with parsimony (and other methods), version 4.0b2a [ M]. Sinauer Associates Lnc. , Sunderland, MA: 1999.
  • 5Kosakovsky Pond SL, Muse SV. HyPhy : Hypothesis testing using phylogenies[ M ]. 2005,p. 1-57. In R. Nielsen (ed.), Statisti- cal Methods in Molecular Evolution, Vol. XII. Springer.
  • 6Berman HM, Westbrook J, Feng Z, et al. The protein data bank [ J]. Nucleic Acids Res, 2000, 28 (1): 235-242.
  • 7Huang H, Chopra R, Verdine GL, et al. Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase : implica- tions for drug resistance [ J ]. Science, 1998, 282 (5394) : 1669- 1675.
  • 8Hepworth J, Bain T, van Driel M. Hepatitis C, mental health and equity of access to antiviral therapy : a systematic narrative re- view[Jl. Int J Equity Health, 2013, 12: 92.
  • 9Pol CTL/CD8 Epitope Map [ DB/OL]. Interactive Epitope Maps, Data last updated at 2016-04-21. http ://www. hiv. lanl. gov/content/immunology/maps/ctl/Pol, html.
  • 10Pennings PS. Standing genetic variation and the evolution of drug resistance in HIV [ J]. PLoS Comput Biol, 2012, 8 (6) : e1002527.

引证文献5

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部